These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 31294131)

  • 1. Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing.
    Kang M; Cho E; Jang J; Lee J; Jeon Y; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Investig Clin Urol; 2019 Jul; 60(4):227-234. PubMed ID: 31294131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
    Anderson CJ; Yang H; Parsons J; Ahrens WA; Jagosky MH; Hsu JH; Patt JC; Kneisl JS; Steuerwald NM
    Clin Orthop Relat Res; 2024 Jun; 483(1):39-48. PubMed ID: 38905450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
    Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
    Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies.
    Weiss S; Lamy P; Rusan M; Nørgaard M; Ulhøi BP; Knudsen M; Kassentoft CG; Farajzadeh L; Jensen JB; Pedersen JS; Borre M; Sørensen KD
    Int J Cancer; 2024 Jul; 155(2):298-313. PubMed ID: 38602058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer.
    Ren T; Suo J; Liu S; Wang S; Shu S; Xiang Y; Lang JH
    J Gynecol Oncol; 2018 Sep; 29(5):e78. PubMed ID: 30022638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-genome/exome analysis of circulating tumor DNA and comparison to tumor genomics from patients with heavily pre-treated ovarian cancer: subset analysis of the PERMED-01 trial.
    Sabatier R; Garnier S; Guille A; Carbuccia N; Pakradouni J; Adelaide J; Provansal M; Cappiello M; Rousseau F; Chaffanet M; Birnbaum D; Mamessier E; Gonçalves A; Bertucci F
    Front Oncol; 2022; 12():946257. PubMed ID: 35965534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
    Beltran H; Yelensky R; Frampton GM; Park K; Downing SR; MacDonald TY; Jarosz M; Lipson D; Tagawa ST; Nanus DM; Stephens PJ; Mosquera JM; Cronin MT; Rubin MA
    Eur Urol; 2013 May; 63(5):920-6. PubMed ID: 22981675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population.
    Suh J; Jeong CW; Choi S; Ku JH; Kim HH; Kim KS; Kwak C
    Investig Clin Urol; 2020 Mar; 61(2):127-135. PubMed ID: 32158963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-coverage whole-genome sequencing of extracellular vesicle-associated DNA in patients with metastatic cancer.
    Nguyen B; Wong NC; Semple T; Clark M; Wong SQ; Leslie C; Mirzai B; Millward M; Meehan K; Lim AM
    Sci Rep; 2021 Feb; 11(1):4016. PubMed ID: 33597619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic markers associated with early cancer-specific mortality following prostatectomy.
    Liu W; Xie CC; Thomas CY; Kim ST; Lindberg J; Egevad L; Wang Z; Zhang Z; Sun J; Sun J; Koty PP; Kader AK; Cramer SD; Bova GS; Zheng SL; Grönberg H; Isaacs WB; Xu J
    Cancer; 2013 Jul; 119(13):2405-12. PubMed ID: 23609948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
    Ledet EM; Lilly MB; Sonpavde G; Lin E; Nussenzveig RH; Barata PC; Yandell M; Nagy RJ; Kiedrowski L; Agarwal N; Sartor O
    Oncologist; 2020 Apr; 25(4):327-333. PubMed ID: 32297439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
    Sudha P; Ahsan A; Ashby C; Kausar T; Khera A; Kazeroun MH; Hsu CC; Wang L; Fitzsimons E; Salminen O; Blaney P; Czader M; Williams J; Abu Zaid MI; Ansari-Pour N; Yong KL; van Rhee F; Pierceall WE; Morgan GJ; Flynt E; Gooding S; Abonour R; Ramasamy K; Thakurta A; Walker BA
    Clin Cancer Res; 2022 Jul; 28(13):2854-2864. PubMed ID: 35522533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue.
    Kader T; Goode DL; Wong SQ; Connaughton J; Rowley SM; Devereux L; Byrne D; Fox SB; Mir Arnau G; Tothill RW; Campbell IG; Gorringe KL
    Genome Med; 2016 Nov; 8(1):121. PubMed ID: 27846907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Analysis of Genomic Alterations across Castration Sensitive and Castration Resistant Prostate Cancer via Circulating Tumor DNA Sequencing.
    Fan L; Fei X; Zhu Y; Pan J; Sha J; Chi C; Gong Y; Du X; Zhou L; Dong B; Xue W
    J Urol; 2021 Feb; 205(2):461-469. PubMed ID: 32897803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products.
    Ferrarini A; Forcato C; Buson G; Tononi P; Del Monaco V; Terracciano M; Bolognesi C; Fontana F; Medoro G; Neves R; Möhlendick B; Rihawi K; Ardizzoni A; Sumanasuriya S; Flohr P; Lambros M; de Bono J; Stoecklein NH; Manaresi N
    PLoS One; 2018; 13(3):e0193689. PubMed ID: 29494651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
    Seed G; Yuan W; Mateo J; Carreira S; Bertan C; Lambros M; Boysen G; Ferraldeschi R; Miranda S; Figueiredo I; Riisnaes R; Crespo M; Rodrigues DN; Talevich E; Robinson DR; Kunju LP; Wu YM; Lonigro R; Sandhu S; Chinnaiyan AM; de Bono JS
    Clin Cancer Res; 2017 Oct; 23(20):6070-6077. PubMed ID: 28751446
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomewide copy number alteration screening of circulating plasma DNA: potential for the detection of incipient tumors.
    Lenaerts L; Vandenberghe P; Brison N; Che H; Neofytou M; Verheecke M; Leemans L; Maggen C; Dewaele B; Dehaspe L; Vanderschueren S; Dierickx D; Vandecaveye V; Amant F; Vermeesch JR
    Ann Oncol; 2019 Jan; 30(1):85-95. PubMed ID: 30371735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility and performance of a novel probe panel to detect somatic DNA copy number alterations in clinical specimens for predicting prostate cancer progression.
    Liu W; Hou J; Petkewicz J; Na R; Wang CH; Sun J; Gallagher J; Bogachkov YY; Swenson L; Regner M; Resurreccion WK; Isaacs WB; Brendler CB; Crawford S; Zheng SL; Helfand BT; Xu J
    Prostate; 2020 Oct; 80(14):1253-1262. PubMed ID: 32803894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of somatic copy number alterations in cancer using targeted exome capture sequencing.
    Lonigro RJ; Grasso CS; Robinson DR; Jing X; Wu YM; Cao X; Quist MJ; Tomlins SA; Pienta KJ; Chinnaiyan AM
    Neoplasia; 2011 Nov; 13(11):1019-25. PubMed ID: 22131877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.